1
Walter Kicinski, Christine White: System for monitoring plant assets including machinery. Bently Nevada Corporation, Dennis DeBoo, June 11, 2002: US06405139 (40 worldwide citation)

A system for monitoring machine data which avoids the need for the cumbersome placement of junction boxes adjacent machines that heretofore had required installing the junction boxes on walls, studs, or stanchions. Instead, a rigid conduit having conductors therein communicate with an integrated sea ...


2
Christine White, Antonio Grillo Lopez: Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody. Biogen Idec, Wendy Lee, Ginger R Dreger, Arnold & Porter, October 15, 2013: US08557244 (35 worldwide citation)

This invention concerns methods for the treatment of intermediate and high-grade non-Hodgkins lymphomas, comprising the administration of anti-CD20 monoclonal antibodies and fragments thereof. Particular embodiments include the administration of chimeric anti-CD20 antibody, either alone or in combin ...


3
Christine White: Treatment of B-cell associated diseases. IDEC Pharmaceuticals Corporation, Pillsbury Winthrop, January 25, 2005: US06846476 (29 worldwide citation)

Treatment of B-cell associated diseases including autoimmune and B-cell malignancies such as leukemias, lymphomas, using the combination of an anti-CD20 antibody, preferably RITUXAN® and a radiolabeled anti-CD22 antibody, preferably an 90Y labeled humanized anti-CD22 antibody, is described. These th ...


4
Janet Christine White, Terence James Ward: Heterocyclic compounds. John Wyeth &Amp Rother, LU XINHUA, October 28, 1992: CN91102395

The following formula is preparaed method of compounds and their acid addition salt. In the formula, R' denotes hydrogen or one or several stipulated substituent, X denotes-O- or _NR2-, where R2 is low grade alkyl, low grade chain olefinyl, low grade alkynyl, aryl or stipulated sustitution low grade ...


5
Gerald Bradley, Janet Christine White, Terence James Ward: Aroyl-urres. John Wyeth &Amp Brother, LU XINHUA, April 24, 1991: CN90108269

(Endo)-N-[[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]carbonyl]-2-( cyclop r opylmethoxy)benzamide and its pharmaceutically acceptable acid addition salts are useful as 5-HT3-antagonists, e.g. in the treatment of anxiety.


6
Christine White: Treatment of B-cell associated diseases such as malignances and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination. Pillsbury Winthrop, April 4, 2002: US20020039557-A1

Treatment of B-cell associated diseases including autoimmune and B-cell malignancies such as leukemias, lymphomas, using the combination of an anti-CD20 antibody, preferably RITUXAN® and a radiolabeled anti-CD22 antibody, preferably an 90Y labeled humanized anti-CD22 antibody, is described. These th ...


7
Christine White: Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination. IDEC Pharmaceuticals Corporation, Pillsbury Winthrop, May 26, 2005: US20050112060-A1

Treatment of B-cell associated diseases including autoimmune and B-cell malignancies such as leukemias, lymphomas, using the combination of an anti-CD20 antibody, preferably RITUXAN® and a radiolabeled anti-CD22 antibody, preferably an 90Y labeled humanized anti-CD22 antibody, is described. These th ...


8

9